Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure

Acute Liver Failure Study Group

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background & Aims: Acute liver failure (ALF) is a syndrome characterized by an intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF). Platelet-derived microparticles increase in proportion to the severity of the SIRS and MOSF, and are associated with poor outcome. We investigated whether patients with ALF develop thrombocytopenia in proportion to the SIRS, MOSF, and poor outcome. Methods: In a retrospective study, we collected data on the post-admission platelet counts of 1598 patients included in the ALF Study Group Registry from 1998 through October 2012. We investigated correlations between platelet counts and clinical features of ALF, laboratory test results, and outcomes. Of the patients studied, 752 (47%) survived without liver transplantation, 390 (24%) received liver transplants, and 517 (32%) died. Results: In patients with SIRS, platelet counts decreased 2 to 7 days after admission, compared with patients without SIRS (P ≤ .001). Patients with abnormal levels of creatinine, phosphate, lactate, or bicarbonate had significantly lower platelet counts than patients with normal levels of these laboratory values (all P ≤ .001). The decrease in platelets during days 1 to 7 after admission was proportional to the grade of hepatic encephalopathy and requirement for vasopressor and renal replacement therapy. Although platelet numbers decreased after admission in the overall population, platelets were significantly lower 2 to 7 days after admission in patients with outcomes of death or liver transplantation than in patients who made spontaneous recoveries and survived. In contrast, international normalized ratios over time were not associated with SIRS, laboratory test results associated with poor outcomes, grade of hepatic encephalopathy, or requirement for renal replacement therapy. Conclusions: The development of thrombocytopenia in patients with ALF is associated with the development of MOSF and poor outcome. We speculate that SIRS-induced activation of platelets, yielding microparticles, results in clearance of platelet remnants and subsequent thrombocytopenia.

Original languageEnglish (US)
Pages (from-to)613-620.e4
JournalClinical Gastroenterology and Hepatology
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Acute Liver Failure
Thrombocytopenia
Platelet Count
Blood Platelets
Renal Replacement Therapy
Hepatic Encephalopathy
Liver Transplantation
International Normalized Ratio
Patient Admission
Platelet Activation
Bicarbonates
Registries
Lactic Acid
Creatinine
Retrospective Studies
Phosphates
Transplants
Liver

Keywords

  • Blood Cell
  • Hemostasis
  • INR
  • Plasma Membrane Fragmentation

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure. / Acute Liver Failure Study Group.

In: Clinical Gastroenterology and Hepatology, Vol. 14, No. 4, 01.04.2016, p. 613-620.e4.

Research output: Contribution to journalArticle

@article{38f6884de6314011b701bc88382fbc77,
title = "Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure",
abstract = "Background & Aims: Acute liver failure (ALF) is a syndrome characterized by an intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF). Platelet-derived microparticles increase in proportion to the severity of the SIRS and MOSF, and are associated with poor outcome. We investigated whether patients with ALF develop thrombocytopenia in proportion to the SIRS, MOSF, and poor outcome. Methods: In a retrospective study, we collected data on the post-admission platelet counts of 1598 patients included in the ALF Study Group Registry from 1998 through October 2012. We investigated correlations between platelet counts and clinical features of ALF, laboratory test results, and outcomes. Of the patients studied, 752 (47{\%}) survived without liver transplantation, 390 (24{\%}) received liver transplants, and 517 (32{\%}) died. Results: In patients with SIRS, platelet counts decreased 2 to 7 days after admission, compared with patients without SIRS (P ≤ .001). Patients with abnormal levels of creatinine, phosphate, lactate, or bicarbonate had significantly lower platelet counts than patients with normal levels of these laboratory values (all P ≤ .001). The decrease in platelets during days 1 to 7 after admission was proportional to the grade of hepatic encephalopathy and requirement for vasopressor and renal replacement therapy. Although platelet numbers decreased after admission in the overall population, platelets were significantly lower 2 to 7 days after admission in patients with outcomes of death or liver transplantation than in patients who made spontaneous recoveries and survived. In contrast, international normalized ratios over time were not associated with SIRS, laboratory test results associated with poor outcomes, grade of hepatic encephalopathy, or requirement for renal replacement therapy. Conclusions: The development of thrombocytopenia in patients with ALF is associated with the development of MOSF and poor outcome. We speculate that SIRS-induced activation of platelets, yielding microparticles, results in clearance of platelet remnants and subsequent thrombocytopenia.",
keywords = "Blood Cell, Hemostasis, INR, Plasma Membrane Fragmentation",
author = "{Acute Liver Failure Study Group} and Stravitz, {R. Todd} and Caitlyn Ellerbe and Valerie Durkalski and Adrian Reuben and Ton Lisman and Lee, {William M.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.cgh.2015.09.029",
language = "English (US)",
volume = "14",
pages = "613--620.e4",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure

AU - Acute Liver Failure Study Group

AU - Stravitz, R. Todd

AU - Ellerbe, Caitlyn

AU - Durkalski, Valerie

AU - Reuben, Adrian

AU - Lisman, Ton

AU - Lee, William M.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background & Aims: Acute liver failure (ALF) is a syndrome characterized by an intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF). Platelet-derived microparticles increase in proportion to the severity of the SIRS and MOSF, and are associated with poor outcome. We investigated whether patients with ALF develop thrombocytopenia in proportion to the SIRS, MOSF, and poor outcome. Methods: In a retrospective study, we collected data on the post-admission platelet counts of 1598 patients included in the ALF Study Group Registry from 1998 through October 2012. We investigated correlations between platelet counts and clinical features of ALF, laboratory test results, and outcomes. Of the patients studied, 752 (47%) survived without liver transplantation, 390 (24%) received liver transplants, and 517 (32%) died. Results: In patients with SIRS, platelet counts decreased 2 to 7 days after admission, compared with patients without SIRS (P ≤ .001). Patients with abnormal levels of creatinine, phosphate, lactate, or bicarbonate had significantly lower platelet counts than patients with normal levels of these laboratory values (all P ≤ .001). The decrease in platelets during days 1 to 7 after admission was proportional to the grade of hepatic encephalopathy and requirement for vasopressor and renal replacement therapy. Although platelet numbers decreased after admission in the overall population, platelets were significantly lower 2 to 7 days after admission in patients with outcomes of death or liver transplantation than in patients who made spontaneous recoveries and survived. In contrast, international normalized ratios over time were not associated with SIRS, laboratory test results associated with poor outcomes, grade of hepatic encephalopathy, or requirement for renal replacement therapy. Conclusions: The development of thrombocytopenia in patients with ALF is associated with the development of MOSF and poor outcome. We speculate that SIRS-induced activation of platelets, yielding microparticles, results in clearance of platelet remnants and subsequent thrombocytopenia.

AB - Background & Aims: Acute liver failure (ALF) is a syndrome characterized by an intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF). Platelet-derived microparticles increase in proportion to the severity of the SIRS and MOSF, and are associated with poor outcome. We investigated whether patients with ALF develop thrombocytopenia in proportion to the SIRS, MOSF, and poor outcome. Methods: In a retrospective study, we collected data on the post-admission platelet counts of 1598 patients included in the ALF Study Group Registry from 1998 through October 2012. We investigated correlations between platelet counts and clinical features of ALF, laboratory test results, and outcomes. Of the patients studied, 752 (47%) survived without liver transplantation, 390 (24%) received liver transplants, and 517 (32%) died. Results: In patients with SIRS, platelet counts decreased 2 to 7 days after admission, compared with patients without SIRS (P ≤ .001). Patients with abnormal levels of creatinine, phosphate, lactate, or bicarbonate had significantly lower platelet counts than patients with normal levels of these laboratory values (all P ≤ .001). The decrease in platelets during days 1 to 7 after admission was proportional to the grade of hepatic encephalopathy and requirement for vasopressor and renal replacement therapy. Although platelet numbers decreased after admission in the overall population, platelets were significantly lower 2 to 7 days after admission in patients with outcomes of death or liver transplantation than in patients who made spontaneous recoveries and survived. In contrast, international normalized ratios over time were not associated with SIRS, laboratory test results associated with poor outcomes, grade of hepatic encephalopathy, or requirement for renal replacement therapy. Conclusions: The development of thrombocytopenia in patients with ALF is associated with the development of MOSF and poor outcome. We speculate that SIRS-induced activation of platelets, yielding microparticles, results in clearance of platelet remnants and subsequent thrombocytopenia.

KW - Blood Cell

KW - Hemostasis

KW - INR

KW - Plasma Membrane Fragmentation

UR - http://www.scopus.com/inward/record.url?scp=84960831325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960831325&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2015.09.029

DO - 10.1016/j.cgh.2015.09.029

M3 - Article

VL - 14

SP - 613-620.e4

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 4

ER -